Tuesday, March 17, 2026

Celltrion’s CT-P55: What Changes to FDA Clinical Trials Mean for Biosimilarity with Cosentyx?

Celltrion has applied to the FDA for changes to its Phase 3 trial of CT-P55, reducing participants to 153 to assess biosimilarity to Cosentyx.

China’s Shipbuilding Surge: How South Korea Lost Its Global Lead

In August, South Korea's shipbuilding industry had its worst order performance of the year, securing just 2% of the global market.

TRUMP’S $90,000,000,000 MISTAKE: Supreme Court Could Force US To Refund ALL Reciprocal Tariffs

Trump claims losing the tariff lawsuit could cost over $2 trillion, stressing national security and legality concerns as the Supreme Court deliberates.

Tag: nobel prize

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.